Live feed08:00:00·4mPRReleasevia QuantisnowRein Therapeutics Receives U.S. FDA Fast Track Designation for LTI-03 in Idiopathic Pulmonary FibrosisByQuantisnow·Wall Street's wire, on your screen.RNTX· Rein Therapeutics Inc.Health Care
